Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free PARK Stock Alerts

Park Dental Partners (PARK) Competitors

$20.91 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$21.09 +0.18 (+0.86%)
As of 07/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

PARK vs. AUNA, SBC, AIRS, BDSX, and LFMD

Should you buy Park Dental Partners stock or one of its competitors? MarketBeat compares Park Dental Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Park Dental Partners include Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), Biodesix (BDSX), and LifeMD (LFMD). These companies are all part of the "healthcare" industry.

How does Park Dental Partners compare to Auna?

Park Dental Partners (NASDAQ:PARK) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Auna has a net margin of 1.53% compared to Park Dental Partners' net margin of 0.00%. Auna's return on equity of 16.25% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Auna 1.53%16.25%4.03%

Park Dental Partners presently has a consensus price target of $21.75, indicating a potential upside of 4.02%. Auna has a consensus price target of $6.97, indicating a potential upside of 32.07%. Given Auna's higher possible upside, analysts clearly believe Auna is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Auna
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40

Auna has higher revenue and earnings than Park Dental Partners. Auna is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$248.15M0.38-$360K$0.7428.26
Auna$1.23B0.32$27.39M$0.2620.29

In the previous week, Auna had 2 more articles in the media than Park Dental Partners. MarketBeat recorded 2 mentions for Auna and 0 mentions for Park Dental Partners. Auna's average media sentiment score of 0.12 beat Park Dental Partners' score of 0.00 indicating that Auna is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Neutral
Auna Neutral

Summary

Auna beats Park Dental Partners on 9 of the 14 factors compared between the two stocks.

How does Park Dental Partners compare to SBC Medical Group?

Park Dental Partners (NASDAQ:PARK) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

In the previous week, Park Dental Partners' average media sentiment score of 0.00 equaled SBC Medical Group'saverage media sentiment score.

Company Overall Sentiment
Park Dental Partners Neutral
SBC Medical Group Neutral

Park Dental Partners currently has a consensus target price of $21.75, indicating a potential upside of 4.02%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 161.54%. Given SBC Medical Group's higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

60.8% of SBC Medical Group shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

SBC Medical Group has lower revenue, but higher earnings than Park Dental Partners. SBC Medical Group is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$248.15M0.38-$360K$0.7428.26
SBC Medical Group$173.61M1.92$50.99M$0.398.33

SBC Medical Group has a net margin of 24.09% compared to Park Dental Partners' net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
SBC Medical Group 24.09%15.90%11.61%

Summary

SBC Medical Group beats Park Dental Partners on 9 of the 14 factors compared between the two stocks.

How does Park Dental Partners compare to AirSculpt Technologies?

AirSculpt Technologies (NASDAQ:AIRS) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Park Dental Partners has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AirSculpt Technologies$151.82M2.10-$11.67M-$0.17N/A
Park Dental Partners$248.15M0.38-$360K$0.7428.26

Park Dental Partners has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -7.39%. Park Dental Partners' return on equity of 0.00% beat AirSculpt Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
AirSculpt Technologies-7.39% -4.98% -2.36%
Park Dental Partners N/A N/A N/A

91.5% of AirSculpt Technologies shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by insiders. Comparatively, 10.6% of Park Dental Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

AirSculpt Technologies presently has a consensus price target of $4.50, indicating a potential downside of 0.44%. Park Dental Partners has a consensus price target of $21.75, indicating a potential upside of 4.02%. Given Park Dental Partners' stronger consensus rating and higher possible upside, analysts clearly believe Park Dental Partners is more favorable than AirSculpt Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AirSculpt Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

In the previous week, AirSculpt Technologies' average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company Overall Sentiment
AirSculpt Technologies Neutral
Park Dental Partners Neutral

Summary

Park Dental Partners beats AirSculpt Technologies on 10 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-33.26% -2,101.40% -35.65%
Park Dental Partners N/A N/A N/A

In the previous week, Biodesix's average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company Overall Sentiment
Biodesix Neutral
Park Dental Partners Neutral

Park Dental Partners has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$88.50M2.57-$35.26M-$4.06N/A
Park Dental Partners$248.15M0.38-$360K$0.7428.26

21.0% of Biodesix shares are owned by institutional investors. 23.2% of Biodesix shares are owned by insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Biodesix presently has a consensus target price of $28.33, indicating a potential upside of 28.85%. Park Dental Partners has a consensus target price of $21.75, indicating a potential upside of 4.02%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

Summary

Park Dental Partners beats Biodesix on 8 of the 14 factors compared between the two stocks.

How does Park Dental Partners compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Comparatively, 10.6% of Park Dental Partners shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

LifeMD has a net margin of 2.37% compared to Park Dental Partners' net margin of 0.00%. Park Dental Partners' return on equity of 0.00% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD2.37% -150.88% -22.59%
Park Dental Partners N/A N/A N/A

LifeMD has higher earnings, but lower revenue than Park Dental Partners. Park Dental Partners is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$194.05M1.21$14.35M$0.0597.40
Park Dental Partners$248.15M0.38-$360K$0.7428.26

In the previous week, LifeMD's average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company Overall Sentiment
LifeMD Neutral
Park Dental Partners Neutral

LifeMD currently has a consensus price target of $9.14, indicating a potential upside of 87.74%. Park Dental Partners has a consensus price target of $21.75, indicating a potential upside of 4.02%. Given LifeMD's higher probable upside, analysts clearly believe LifeMD is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

Summary

LifeMD beats Park Dental Partners on 8 of the 14 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PARK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PARK vs. The Competition

Export
MetricPark Dental PartnersServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$94.41M$2.07B$24.85B$12.48B
Dividend YieldN/AN/A5.29%6.52%
P/E Ratio28.2624.8118.3624.70
Price / Sales0.388.1041.4199.49
Price / Cash4.762,169.72362.7757.09
Price / Book3.9230.6313.446.46
Net Income-$360K-$30.36M-$12.63M$337.01M
7 Day Performance7.29%2.47%21.20%1.69%
1 Month Performance10.28%11.11%6.87%3.81%
1 Year PerformanceN/AN/A-11.35%23.90%

Park Dental Partners Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PARK
Park Dental Partners
2.3671 of 5 stars		$20.91
flat		$21.75
+4.0%		N/A$94.41M$248.15M28.261,212
AUNA
Auna
4.8991 of 5 stars		$5.02
+0.2%		$6.97
+38.8%		-16.7%$371.55M$4.52B19.3115,254
SBC
SBC Medical Group
4.0394 of 5 stars		$3.14
-0.5%		$8.50
+171.1%		-27.6%$321.17M$169.34M8.03N/A
AIRS
AirSculpt Technologies
1.0008 of 5 stars		$4.45
-1.5%		$4.50
+1.1%		-15.4%$314.99M$151.84MN/A240
BDSX
Biodesix
3.4706 of 5 stars		$23.07
-3.1%		$28.33
+22.8%		+298.4%$248.86M$96.10MN/A220

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PARK) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel